FDA to review OTC cough medicine safety

The FDA says it's convening an expert panel to review over-the-counter cough and cold medicines for children because of concerns about their safety. The agency began looking into the drugs at the prompting of public health officials worries by reports of hundreds of overdoses and several deaths.

Doctors have asked the FDA to require labels on the products stating that they haven't been proven effective in kids under six. In advance of the planned Oct. 18 meeting, the FDA warned parents not to give cough and cold remedies to children under two without a doctor's approval.

- see the FDA's public health advisory
- read the report from The Washington Post
- here's the Wall Street Journal report (sub. req.)

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.